Literature DB >> 28321924

Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine.

Markus Radsak1, Uwe Platzbecker2, Cornelia S Schmidt1, Wolf-Karsten Hofmann3, Florian Nolte3.   

Abstract

Myelodysplastic Syndromes are oligo-clonal stem cell disorders that are associated with cytopenias in the peripheral blood. Major causes for morbidity and mortality in myelodysplastic syndromes (MDS) patients are infections mostly due to bacteria or fungi. Beside leucopenia per se in affected patients, function of white blood cells particularly that of neutrophils seems to be impaired. Here we summarize the available data on infections in MDS patients in general and particularly those treated with 5-azacitidine.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  5-azacitidine; infection; myelodysplastic syndromes; socioeconomics and ethics; supportive care

Mesh:

Substances:

Year:  2017        PMID: 28321924     DOI: 10.1111/ejh.12883

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  3 in total

Review 1.  Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?

Authors:  Martin Voss; Johanna Kotrba; Evelyn Gaffal; Konstantinos Katsoulis-Dimitriou; Anne Dudeck
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

2.  Increased prescription rate of anti-infective agents after diagnosis of myelodysplastic syndromes.

Authors:  Johanne Rozema; Mels Hoogendoorn; Iris Potma; Inge Ten Seldam; Nic J G M Veeger; Robby E Kibbelaar; Arjan A van de Loosdrecht; Eric N van Roon
Journal:  EJHaem       Date:  2022-03-25

Review 3.  Infections in Myelodysplastic Syndrome in Relation to Stage and Therapy.

Authors:  Giuseppe Leone; Livio Pagano
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-07-01       Impact factor: 3.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.